CMND PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

CMND ▼ -18.72% at T+5d

NEUTRAL call ✗ call lost -18.72% · α vs SPY -18.42% · entry $3.58 → $2.91

Next anchor: T+20d in 14d

Last close $3.34 (close Jun 12) · -6.70% from $3.58 entry

Entry anchored
May 28, 03:01 PM ET
via Databento tick

T+1d

-11.45%

call -11.45% · α -11.73%

$3.17

settled 14d ago

T+5d

-18.72%

call -18.72% · α -18.42%

$2.91

settled 10d ago

T+20d

—

call — · α —

—

in 14d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Clearmind Medicine announced a Japanese patent application for its MEAI-based depression treatment, expanding its IP portfolio. The press release contains no financial data or clinical results, only forward-looking statements about market growth and pipeline expansion.

Actionable Insight

This is a routine IP update with no hard catalysts. Monitor for clinical trial results or regulatory filings that could move the stock. Given the $2M market cap and historical volatility, any news could cause outsized moves, but this specific announcement lacks materiality.

Key Facts

Filed a Japanese patent application for MEAI compositions to treat depression
MEAI is a non-hallucinogenic neuroplastogen molecule
Company has 19 patent families and 31 granted patents globally
No financial data, clinical trial results, or regulatory milestones disclosed
Market cap is approximately $2M

Financial Impact

No financial figures disclosed; patent application is a procedural IP step with no immediate revenue impact

Risk Factors

No guarantee the Japanese patent will be granted
Company is pre-revenue clinical-stage with no approved products
Forward-looking statements about market growth are speculative
Low market cap ($2M) increases susceptibility to dilution or delisting risk

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3303585

33 reports for CMND

T+1T+5T+20T+60

50% Hit rate 6 of 12 directional calls best @ T+20▲ +71.18%Apr 20, 2026

Filters

Reports for CMND — sortable, filterable
	Type				Now
Jun 12, 2026 2d ago	3 NEUTRAL ★ 2/10	$3.36 awaiting T+5	awaiting T+5	—	$3.34 (−0.60%)
Jun 5, 2026 9d ago	Press Release NEUTRAL ★ 2/10	$2.76 awaiting T+5	awaiting T+5	—	$3.34 (+21.01%)
May 29, 2026 16d ago	6-K NEUTRAL ★ 3/10	$3.58 $2.91	▼ −18.72%	▼ −18.42%	$3.34 (−6.70%)
May 29, 2026 16d ago	Press Release NEUTRAL ★ 3/10	$3.58 $2.91	▼ −18.72%	▼ −18.42%	$3.34 (−6.70%)
May 26, 2026 19d ago	6-K NEUTRAL ★ 4/10	$2.59 $3.17	▲ +22.39%	▲ +21.31%	$3.34 (+28.96%)
May 26, 2026 19d ago	Press Release NEUTRAL ★ 4/10	$2.59 $3.17	▲ +22.39%	▲ +21.31%	$3.34 (+28.96%)
May 19, 2026 26d ago	6-K BEARISH ★ 6/10	$2.36 $2.58	▼ −9.28%	▼ −7.04%	$3.34 (−41.53%)
May 19, 2026 26d ago	6-K NEUTRAL ★ 4/10	$2.36 $2.58	▲ +9.28%	▲ +7.04%	$3.34 (+41.53%)
May 19, 2026 26d ago	Press Release BEARISH ★ 5/10	$2.36 $2.58	▼ −9.28%	▼ −7.04%	$3.34 (−41.53%)
May 18, 2026 27d ago	6-K BEARISH ★ 7/10	$2.36 $2.58	▼ −9.28%	▼ −7.04%	$3.34 (−41.53%)

US Market Status

Market Closed — Opens in 4h 33m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access